major depressive disorder

Here's Why Sage Therapeutics Lost 53.3% in December
Motley Fool
Mon, 01/6/20 - 11:28 pm
SAGE Therapeutics
SAGE-217
major depressive disorder
clinical trials
How Big of a Deal Is Axsome Therapeutics' New Depression Drug?
Motley Fool
Wed, 12/18/19 - 11:51 pm
Axsome Therapeutics
AXS-05
major depressive disorder
3 Biotech Stocks With Big Incoming Catalysts
Motley Fool
Mon, 12/16/19 - 10:52 am
Axsome Therapeutics
AXS-05
Solid Biosciences
SGT-001
Duchenne Muscular Dystrophy
major depressive disorder
Intra-Cellular Therapies
lumateperone
schizophrenia
Axsome’s Depression Drug Meets Phase 3 Goals, FDA Filing Planned
Xconomy
Mon, 12/16/19 - 10:38 am
Axsome Therapeutics
AXS-05
major depressive disorder
clinical trials
Sage Therapeutics Depression Drug Fails in Phase 3, Shares Fall 60%
Xconomy
Thu, 12/5/19 - 10:11 am
SAGE Therapeutics
clinical trials
SAGE-217
major depressive disorder
FDA tags psilocybin drug as clinical depression Breakthrough Therapy
Pharmaforum
Mon, 12/2/19 - 09:46 am
FDA
psilocybin
major depressive disorder
Usona
PSIL201
VistaGen fails phase 2 depression trial, sparking stock rout
Fierce Biotech
Thu, 11/14/19 - 10:36 am
VistaGen
AV-101
major depressive disorder
clinical trials
Upcoming events – Sage targets depression and Biogen aims for lupus
EP Vantage
Fri, 10/4/19 - 10:03 am
SAGE Therapeutics
SAGE-217
major depressive disorder
Biogen
BIIB059
lupus
FDA Overlooked Red Flags In Drugmaker’s Testing of New Depression Medicine
KHN
Tue, 06/11/19 - 11:41 pm
FDA
Janssen
Spravato
esketamine
major depressive disorder
Otsuka, Click to develop digital therapeutics for MDD
Pharmaceutical Business Review
Fri, 01/4/19 - 09:09 am
Otsuka
Click Therapeutics
digital therapeutics
major depressive disorder
More data could be key for Alkermes after FDA panel vote
BioCentury
Sat, 11/3/18 - 03:59 pm
Alkermes
ALKS 5461
major depressive disorder
FDA
Alkermes Depression Drug Faces Long Odds After FDA Advisors Say No
Xconomy
Thu, 11/1/18 - 07:30 pm
Alkermes
FDA
advisory panels
ALKS-5461
major depressive disorder
FDA Blasts Data, Trial Design For Alkermes Depression Drug
Xconomy
Tue, 10/30/18 - 11:34 am
FDA
Alkermes
ALKS 5461
clinical trials
major depressive disorder
Janssen, Lundbeck and Takeda Raise Issues With FDA Draft Guidance on MDD Drugs
RAPS.org
Mon, 08/20/18 - 11:07 pm
FDA
JNJ
Janssen
Lundbeck
Takeda
major depressive disorder
drug development
Sage to Expedite Development of SAGE-217 in Major Depressive Disorder and Postpartum Depression
CP Wire
Tue, 06/12/18 - 10:00 am
SAGE Therapeutics
FDA
breakthrough status
SAGE-217
major depressive disorder
postpartum depression
Sage to Expedite Development of SAGE-217 in Major Depressive Disorder and Postpartum Depression
Tue, 06/12/18 - 09:42 am
SAGE Therapeutics
SAGE-217
major depressive disorder
postpartum depression
Acceptance Growing for BrainsWay’s Depression Therapy
Medical Devices and Diagnostics Industry
Mon, 05/7/18 - 10:09 pm
Brainsway
devices
Deep Transcranial Magnetic Stimulation
major depressive disorder
Study Shows Genetic Test Guided Treatment Significantly Improves Outcomes in Patients with Major Depressive Disorder
CP Wire
Mon, 05/7/18 - 09:31 am
Assurex Health
GeneSight
major depressive disorder
Myriad Genetics
diagnostics
Study Shows Genetic Test Guided Treatment Significantly Improves Outcomes in Patients with Major Depressive Disorder
Mon, 05/7/18 - 09:10 am
Assurex Health
GeneSight
major depressive disorder
FDA Now Accepts Alkermes Application It Rejected Two Weeks Ago
CP Wire
Mon, 04/16/18 - 09:05 am
Alkermes
ALKS-5461
major depressive disorder
FDA

Pages